HANNAH BRAME: Open Payments
NPI 1124790985 · FOUR OAKS, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,050 in 59 payments from 24 companies in 2025. Trend: 2023 $1,146 · 2024 $1,953 · 2025 $1,050
Food & beverage: $1,050
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $135 |
| AstraZeneca Pharmaceuticals LP | 5 | $98 |
| Amgen Inc. | 6 | $92 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $91 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $74 |
| Lilly USA, LLC | 3 | $55 |
| Otsuka America Pharmaceutical, Inc. | 2 | $54 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $53 |
| Corcept Therapeutics | 2 | $44 |
| TOLMAR, INC. | 2 | $40 |
Products named: OTEZLA, CAPLYTA, UBRELVY, REXULTI, Kerendia, XIFAXAN, Korlym, JARDIANCE.
Industry payments across NC — which companies pay providers there.
